
("Time Finance", the "Group" or the "Company")
Extended Funding Facilities
Improved facilities now exceed
James Roberts, Chief Financial Officer, commented:
"I am delighted that the Group has put in place substantial funding facilities as we embark on our new three-year growth plan. The previous plan, from
"As such, the significant headroom provided by these larger and more flexible facilities across all lending divisions position the Group well as it looks to further support UK business requiring funding for business-critical equipment through Asset Finance or working capital solutions through Invoice Finance."
Full Year Results and Investor Presentation
As previously announced on
For more information and the chance to have your questions directly answered by the management team, please head to our interactive investor hub via: https://investors.timefinance.com/s/71ba43. Here you will find all company news and additional content to further explain Time Finance's strategy and developments.
Ends
For further information, please contact: |
|
|
|
|
|
Ed Rimmer, Chief Executive Officer |
01225 474230 |
James Roberts, Chief Financial Officer |
|
|
|
Cavendish Capital Markets (NOMAD and Broker) |
0207 220 0500 |
Ben Jeynes / Teddy Whiley (Corporate Finance) Michael Johnson / Matt Lewis (Sales and ECM) |
|
|
|
Walbrook PR |
0207 933 8780 |
Nick Rome / Joe Walker |
Subscribe to our news alert service: https://investors.timefinance.com/auth/signup
About Time Finance:
Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.
More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the